OKYO
OKYO Pharma Ltd
1.50$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 77.7% | 99.6% | 99.8% | 99.8% | 99.9% | 99.9% | 99.9% | 99.9% | 99.9% | 100.0% | 100.0% | 100.0% | |
| 77.7% | 68.0% | 53.6% | 53.6% | 34.9% | 34.9% | 42.4% | 42.4% | 42.4% | 90.9% | 69.6% | 69.6% | |
| 77.7% | 68.0% | 53.6% | 53.6% | 34.9% | 34.9% | 42.4% | 42.4% | 42.4% | 90.9% | – | 98.2% | |
| 18.8% | 20.9% | – | 37.7% | 20.5% | 53.6% | – | 51.4% | 51.4% | 0.5% | – | 0.8% | |
| 3.3% | – | – | – | – | – | – | – | – | – | – | – | |
| 39.5% | 349.8% | 481.5% | 481.5% | 355.4% | 355.4% | 250.9% | 250.9% | 250.9% | 173.5% | 41.2% | 41.2% | |
| 139.5% | 349.8% | 481.5% | 481.5% | 355.4% | 355.4% | 250.9% | 250.9% | 250.9% | 173.5% | 41.2% | 41.2% | |
| 34.5% | 99.9% | – | – | 0.1% | 0.1% | – | – | – | 4.0% | – | – | |
| 19.7% | – | 397.6% | 397.6% | 339.6% | 308.0% | 214.8% | 214.8% | 214.8% | 153.1% | 34.0% | 34.0% | |
| -39.5% | -249.8% | -381.5% | -381.5% | -255.4% | -255.4% | -150.9% | -150.9% | -150.9% | -73.5% | 58.8% | 58.8% | |
| -2,415.4% | -5,658.6% | -9,247.2% | -9,247.2% | -5,132.9% | -5,132.9% | -3,889.3% | -3,889.4% | -3,889.4% | -3,135.5% | -724.5% | -724.5% | |
| 494.1% | 1,081.7% | 2.1% | 2,139.3% | 1,186.8% | 1,186.8% | 1.2% | 1,073.8% | 979.5% | 805.8% | 250.2% | 178.2% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.